Skip to main navigation Skip to search Skip to main content

Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalCTS-Clinical and Translational Science
StatePublished - 2021.07.1

Cite this